Gayle Oswald
Gayle Oswald's purchase track record
Gayle Oswald has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/13/2026 | LUCYW | $2K | -16.4% | +11.9% | +8.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Innovative Eyewear Reports 55% Q3 Sales Growth. Innovative Eyewear announced preliminary net sales for the third quarter of 2026 that rose 55% compared to the same period last year. This marks a record high for the company's quarterly revenue. The strong sales figure stands in contrast to the stock's recent technical weakness, as the warrants have been trading near their 52-week low despite the improved fundamental performance.
Transaction History
| LUCY | ▲ Buy | Grant | 16,233 | $0 | 8/19/2026 | View on chart |
| LUCY | ▼ Sell | Open Market | 7,959 | $5K | 8/19/2026 | View on chart |
| LUCY | ▲ Buy | Grant | 16,233 | $0 | 4/2/2026 | View on chart |
| LUCY | ▼ Sell | Open Market | 7,574 | $8K | 4/2/2026 | View on chart |
| LUCYW | ▲ Buy | Open Market | 700 | $1K | 1/13/2026 | View on chart |
| LUCYW | ▲ Buy | Open Market | 300 | $507 | 1/13/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Innovative Eyewear Q3 2026 Sales Rise 55%
Innovative Eyewear announced preliminary Q3 2026 net sales of about $1.04 million, a 55 % increase from the same period in 2025. The rise in revenue may support the stock’s current trading near its $1.02 support level. The company’s RSI of 53.0 indicates neither overbought nor oversold conditions. The 52‑week range remains $0.65 to $2.08.
Innovative Eyewear Q3 2026 Sales Rise 55%. Innovative Eyewear announced preliminary Q3 2026 net sales of about $1.04 million, a 55 % increase from the same period in 2025. The rise in revenue may support the stock’s current trading near its $1.02 support level. The company’s RSI of 53.0 indicates neither overbought nor oversold conditions. The 52‑week range remains $0.65 to $2.08.